• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
ProQR Therapeutics released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 13.2 M, actual EPS USD -0.3712
04:00
ProQR Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 3.419 M (forecast USD 7.034 M), actual EPS USD -0.1225 (forecast USD -0.1197)
04:00
Nov5
Analyst Maintains Buy Rating on ProQR Stock
06:22
Oct15
Wolleben's Stock Recommendations Success Rate and Return Rate
13:12
Oct13
ProQR Therapeutics NV to Attend Chardan's 9th Annual Gene Therapy Conference
12:30
Oct1
ProQR Therapeutics stock price breaks above 50-day moving average
09:28

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.419 M, Net Income -12.91 M, EPS -0.1225

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.653 M, Net Income -14.26 M, EPS -0.1404

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 5.132 M, Net Income -10.91 M, EPS -0.1082

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SRXH
0.5642
+85.29%
+0.256
AMCI
13.364
+83.82%
+6.320
VMAR
0.6482
+70.53%
+0.322
VERO
2.625
+57.19%
+0.933
CPAC
10.212
+46.10%
+3.222
BDRX
6.490
+35.77%
+1.710
CHOW
1.050
+34.25%
+0.258
SFWL
1.050
+31.25%
+0.250
AZI
2.010
+30.51%
+0.469
ALDX
5.200
+30.33%
+1.199
View More